
### [NCIT:C9351](http://purl.obolibrary.org/obo/NCIT_C9351)
**Label:** Pleural Mesothelioma

**Subclasses:** [NCIT:C6648](http://purl.obolibrary.org/obo/NCIT_C6648) (Stage III Pleural Malignant Mesothelioma AJCC v7), [NCIT:C136403](http://purl.obolibrary.org/obo/NCIT_C136403) (Stage III Pleural Malignant Mesothelioma AJCC v8), [NCIT:C6647](http://purl.obolibrary.org/obo/NCIT_C6647) (Stage II Pleural Malignant Mesothelioma AJCC v7), [NCIT:C8707](http://purl.obolibrary.org/obo/NCIT_C8707) (Recurrent Pleural Malignant Mesothelioma), [NCIT:C6649](http://purl.obolibrary.org/obo/NCIT_C6649) (Stage IV Pleural Malignant Mesothelioma AJCC v7), [NCIT:C136399](http://purl.obolibrary.org/obo/NCIT_C136399) (Pleural Malignant Mesothelioma by AJCC v8 Stage), [NCIT:C136406](http://purl.obolibrary.org/obo/NCIT_C136406) (Stage IV Pleural Malignant Mesothelioma AJCC v8), [NCIT:C136400](http://purl.obolibrary.org/obo/NCIT_C136400) (Stage I Pleural Malignant Mesothelioma AJCC v8), [NCIT:C4499](http://purl.obolibrary.org/obo/NCIT_C4499) (Pleural Adenomatoid Tumor), [NCIT:C6646](http://purl.obolibrary.org/obo/NCIT_C6646) (Stage I Pleural Malignant Mesothelioma AJCC v7), [NCIT:C45660](http://purl.obolibrary.org/obo/NCIT_C45660) (Pleural Well Differentiated Papillary Mesothelioma), [NCIT:C136402](http://purl.obolibrary.org/obo/NCIT_C136402) (Stage II Pleural Malignant Mesothelioma AJCC v8), [NCIT:C45663](http://purl.obolibrary.org/obo/NCIT_C45663) (Pleural Sarcomatoid Mesothelioma), [NCIT:C7376](http://purl.obolibrary.org/obo/NCIT_C7376) (Pleural Malignant Mesothelioma), [NCIT:C45662](http://purl.obolibrary.org/obo/NCIT_C45662) (Pleural Epithelioid Mesothelioma), [NCIT:C45665](http://purl.obolibrary.org/obo/NCIT_C45665) (Pleural Biphasic Mesothelioma), [NCIT:C45664](http://purl.obolibrary.org/obo/NCIT_C45664) (Pleural Desmoplastic Mesothelioma), [NCIT:C45666](http://purl.obolibrary.org/obo/NCIT_C45666) (Localized Pleural Malignant Mesothelioma), [NCIT:C136374](http://purl.obolibrary.org/obo/NCIT_C136374) (Pleural Malignant Mesothelioma by AJCC v7 Stage), 

**Class expressions from DL-Learner:**

- [UBERON:0002402](http://purl.obolibrary.org/obo/UBERON_0002402) (pleural cavity) 75.00%
- [UBERON:0000977](http://purl.obolibrary.org/obo/UBERON_0000977) (pleura) 75.00%
- [UBERON:0035809](http://purl.obolibrary.org/obo/UBERON_0035809) (serous cavity) 53.87%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 51.60%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 51.45%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 51.44%
- Thing 50.92%
- [UBERON:0002553](http://purl.obolibrary.org/obo/UBERON_0002553) (anatomical cavity) 35.91%
- [UBERON:0000464](http://purl.obolibrary.org/obo/UBERON_0000464) (anatomical space) 32.62%
- [UBERON:0000466](http://purl.obolibrary.org/obo/UBERON_0000466) (immaterial anatomical entity) 32.14%
- [BFO:0000141](http://purl.obolibrary.org/obo/BFO_0000141) (null) 32.14%
- [UBERON:0004119](http://purl.obolibrary.org/obo/UBERON_0004119) (endoderm-derived structure) 28.86%
- [UBERON:0004120](http://purl.obolibrary.org/obo/UBERON_0004120) (mesoderm-derived structure) 27.53%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 26.28%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 26.21%


